127 results on '"Keri, G."'
Search Results
2. Debunking the Myth That Technology Is a Barrier for Volunteer Training Delivery
3. Increasing Extension Volunteer Knowledge and Preparedness with Youth Protection Training Across Program Areas.
4. Characterization of binding mode of imatinib to human α1-acid glycoprotein
5. Screening of peptidomimetic tyrosine kinase inhibitors for inducing programmed cell death
6. Covering and radius-covering arrays: Constructions and classification
7. Letter to the editor regarding “The prevalence and influencing factors of methicillin-resistant Staphylococcus aureus carriage in people in contact with livestock: A systematic review”
8. Aldrin and Dieldrin: A Reevaluation of the Cancer and Noncancer Dose-Response Assessments
9. In vitro and cellular study of benzothiophene- 3-carboxamides as inhibitors of Aurora kinase family: SW04.S16–159
10. Drug selected human lung cancer stem cells in non-small cell lung cancer: P27-115
11. The antiproliferative effect of known and novel PLK1 inhibitors on different cancer cell lines: B2.08
12. Biochemical characterization of novel PKD1 inhibitors using kinase assays and cellular studies: B2.09
13. Biochemical characterization of novel EGFR and c-Met single and dual inhibitors: B2.07
14. Screening a kinase inhibitor library for multiple target inhibitors of VEGFR2 and PDGFRb: B2.06
15. Systematic review and quality ranking of studies of two phthalate metabolites and anogenital distance, bone health, inflammation, and oxidative stress
16. The somatostatin analogue peptide TT-232 induces apoptosis and chromosome breakage in cultured human lymphocytes
17. Aldrin and dieldrin: a reevaluation of the cancer and noncancer dose-response assessments
18. Similarity-based automated evidence ranking for clinical interpretation of multigene diagnostic panels
19. Protein kinase Cζ drives Sphingomyelin Metabolism in the Nucleus during Cell Proliferation
20. Glycemic index and glycemic load are not associated with brain lesions in the elderly
21. PKC zeta INHIBITION PROMOTES APOPTOSIS IN TUMOR CELLS VIA THE SPHINGOMYELIN PATHWAY
22. Intracellular delivery of the p38 mitogen-activated protein kinase Inhibitor SB202190 [4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole] in renal tubular Cells: a novel strategy to treat renal fibrosis
23. 791: Investigation of the mode of action of sunitinib kinase inhibitor profile analogues in insulin release
24. Pharmacophore and Binding Analysis of Known and Novel B-RAF Kinase Inhibitors
25. 140P - Similarity-based automated evidence ranking for clinical interpretation of multigene diagnostic panels
26. Aldrin and Dieldrin: A Reevaluation of the Cancer and Noncancer Dose-Response Assessments
27. Protein Kinase C ζ Drives Sphingomyelin Metabolism in the Nucleus During Cell Proliferation
28. Experimental models of CKD
29. Developing FGFR4 Inhibitors As Potential Anti-Cancer Agents Via In Silico Design, Supported by In Vitro and Cell-Based Testing
30. Developing FGFR4 Inhibitors As Potential Anti-Cancer Agents Via In Silico Design, Supported by In Vitro and Cell-Based Testing
31. Delivery of the p38 MAPkinase inhibitor SB202190 to angiogenic endothelial cells: development of novel RGD-equipped and PEGylated drug-albumin conjugates using platinum(II)-based drug linker technology
32. Delivery of the p38 MAPkinase inhibitor SB202190 to angiogenic endothelial cells: development of novel RGD-equipped and PEGylated drug-albumin conjugates using platinum(II)-based drug linker technology
33. Intracellular delivery of the p38 mitogen-activated protein kinase Inhibitor SB202190 [4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole] in renal tubular Cells: a novel strategy to treat renal fibrosis
34. Mechanisms and targets of glomerular damage
35. Novel, Selective CDK9 Inhibitors for the Treatment of HIV Infection
36. Comparative Characterization of Experimental and Calculated Lipophilicity and Anti-Tumour Activity of Isochromanone Derivatives
37. Use of adult male bonnet monkeys (Macaca radiata) for testing the biological activity of gonadotropin releasing hormone and its analogues
38. Signalling Inhibitors Against Mycobacterium tuberculosis – Early Days of a New Therapeutic Concept in Tuberculosis
39. Use of adult male bonnet monkeys (Macaca radiata) for testing the biological activity of gonadotropin releasing hormone and its analogues
40. Novel lipoamino acid- and liposaccharide-based system for peptide delivery : Application for oral administration of tumor-selective somatostatin analogues
41. Prediction Oriented QSAR Modelling of EGFR Inhibition
42. P-966 Gefitinib treatment in brain metastasis of lung adenocarcinoma with EGFR amplification and mutation (case report)
43. Determination of the basicity of Mannich ketones by capillary electrophoresis
44. The Promotion of Social Awareness: Powerful Lessons from the Partnership of Developmental Theory and Classroom PracticeR.L. Selman, Russell Sage Foundation, New York, 2003, 325 pp.
45. 801: Activation of HER3 interferes with antitumor effects of Axl receptor tyrosine kinase inhibitors − suggestion of combination therapy
46. Novel Somatostatin Analogs with Tyrosine Kinase Inhibitory and Antitumor Activity
47. Protein Kinase Cξ Drives Sphingomyelin Metabolism in the Nucleus During Cell Proliferation
48. Inhibition of c-Met with the Specific Small Molecule Tyrosine Kinase Inhibitor SU11274 Decreases Growth and Metastasis Formation of Experimental Human Melanoma
49. Structure−Activity Relationship Studies Optimizing the Antiproliferative Activity of Novel Cyclic Somatostatin Analogues Containing a Restrained Cyclic β-Amino Acid
50. Acid−Base Profiling of Imatinib (Gleevec) and Its Fragments
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.